Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Ono

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Ono's Japan sales performance.

Bayer bags FDA nod for early prostate cancer drug darolutamide

Bayer bags FDA nod for early prostate cancer drug darolutamide Bayer says it has also submitted darolutamide in the EU, Japan, and additional countries around the world.

CHMP backs Bayer’s tumour-agnostic drug Vitrakvi

CHMP backs Bayer’s tumour-agnostic drug Vitrakvi Entrectinib has just been approved in Japan, its first market, as Rozlytrek.

ACPs to lead gene therapies in haemophilia market growth

ACPs to lead gene therapies in haemophilia market growth GlobalData found that key opinion leaders in the eight major markets (the US, France, Germany, Italy, Spain, UK, Japan, and China) are highly optimistic about these therapies and agree that they

Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease

Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease trial programme for imeglimin outside Japan, where two phase 3 studies have already generated positive results in diabetes. ... drug. The French company signed an agreement with Sumitomo Dainippon Pharma in 2017 for development rights to the drug in

CHMP blocks UCB/Amgen’s Evenity approval for osteoporosis

CHMP blocks UCB/Amgen’s Evenity approval for osteoporosis Evenity was filed in the US and Japan in 2016 on the strength of the FRAME study, which showed impressive activity in reducing fracture rates and improving bone mineral density in

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics